AMI Organics Ltd - Stock Valuation and Financial Performance

BSE: 543349 | NSE: AMIORG | Pharmaceuticals & Drugs | Small Cap

AMI Organics Share Price

1,976.85 56.75 2.96%
as on 31-Oct'24 16:01

DeciZen - make an informed investing decision on AMI Organics

Overall Rating
Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

AMI Organics stock performance -

mw4me loader
P/E Ratio (SA):
81.59
Market Cap:
8,092.1 Cr.
52-wk low:
1,005.1
52-wk high:
1,987.4

Is AMI Organics Ltd an attractive stock to invest in?

1. Is AMI Organics Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that AMI Organics Ltd is a average quality company.

2. Is AMI Organics Ltd undervalued or overvalued?

The key valuation ratios of AMI Organics Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is AMI Organics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of AMI Organics Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of AMI Organics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
AMI Organics Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 25%42.7%35.8%37.8%35%26.7%33.1%23.9%20.7%10.2%-
Value Creation
Index
0.92.21.71.81.50.91.40.70.5-0.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 112154160188236240341520617688796
Sales YoY Gr.-37.5%4.3%17.5%25.2%1.7%42.1%52.7%18.6%11.5%-
Adj EPS 1.33.53.85.37.78.65.719.722.615.724.2
YoY Gr.-170%7.7%40.2%45.5%12.1%-33.7%244.5%14.5%-30.7%-
BVPS (₹) 4.78.712.518.425.834.317.4142.2161182.4294
Adj Net
Profit
4.11111.916.724.327.254.171.982.457.899
Cash Flow from Ops. -3.910.128.81021.827.326.9-9.755.7101-
Debt/CF from Ops. -5.92.90.94.42.52.25.1-0.10.12-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 22.4%23.9%26.4%11.5%
Adj EPS 31.9%15.3%39.9%-30.7%
BVPS50.1%47.9%119.1%13.3%
Share Price - - 22.8% 70.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
3252.235.734.434.928.839.821.114.99.210.2
Op. Profit
Mgn %
7.411.814.416.218.217.523.820.22015.717.3
Net Profit
Mgn %
3.77.27.48.910.311.415.913.813.48.412.5
Debt to
Equity
1.61.10.70.80.70.60.8000.30
Working Cap
Days
131137150148164188181195224240117
Cash Conv.
Cycle
32383030365256729010672

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 26.38%

Net Profit is growing at healthy rate in last 3 years 39.87%

Sales growth is good in last 4 quarters at 23.31%

Return on Equity has declined versus last 3 years average to 10.20%

Latest Financials - AMI Organics Ltd.

Standalone Consolidated
TTM EPS (₹) 24.2 22.8
TTM Sales (₹ Cr.) 796 815
BVPS (₹.) 294 293.7
Reserves (₹ Cr.) 1,162 1,161
P/BV 6.72 6.73
PE 81.59 86.84
From the Market
52 Week Low / High (₹) 1005.05 / 1987.40
All Time Low / High (₹) 764.15 / 1987.40
Market Cap (₹ Cr.) 8,092
Equity (₹ Cr.) 40.9
Face Value (₹) 10
Industry PE 46.8

Management X-Ray of AMI Organics:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of AMI Organics

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales112154160188236240341520617688
Operating Expenses 103136137158193199260415494580
Manufacturing Costs9161621213946716972
Material Costs679195113149129180273331408
Employee Cost 47710111821414961
Other Costs 23211814111314304539
Operating Profit 8182331434180105123108
Operating Profit Margin (%) 7.4%11.8%14.4%16.2%18.2%17.1%23.5%20.2%19.9%15.7%
Other Income 03031313414
Interest 2333566626
Depreciation 1112344101215
Exceptional Items 000000000-32
Profit Before Tax 61819283735729111269
Tax 2571012718202925
Profit After Tax 4131218252754728344
PAT Margin (%) 3.7%8.2%7.5%9.8%10.5%11.5%15.9%13.8%13.5%6.4%
Adjusted EPS (₹)1.34.03.85.97.88.75.719.822.911.9
Dividend Payout Ratio (%)0%0%0%0%0%0%0%15%13%25%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 1527395881108164518587673
Share Capital 2222111132363637
Reserves 132638567197132482550636
Minority Interest0000000000
Debt21272341485411713172
Long Term Debt616143122207310114
Short Term Debt1411992634450359
Trade Payables20283848695185118139133
Others Liabilities 3889141544183093
Total Liabilities 59911091552122284106557591,071

Fixed Assets

Gross Block111522247075177204261410
Accumulated Depreciation66810121317273953
Net Fixed Assets6915155862161178222357
CWIP 4411302120330125
Investments 0111521282833333368
Inventories14202027395260112119151
Trade Receivables243636507353119162230213
Cash Equivalents 1131032995932
Others Assets10118111218366866125
Total Assets 59911091552122284106557591,071

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity -4102910222727-1056101
PBT 61819283735729111269
Adjustment 2344579121142
Changes in Working Capital -11-713-15-6-7-40-91-436
Tax Paid -1-3-7-8-14-8-14-23-24-16
Cash Flow From Investing Activity -4-14-19-27-25-24-101-122-20-337
Capex -4-3-15-21-17-19-102-33-84-274
Net Investments 0-11-4-6-8-51-9261-40
Others 000000032-23
Cash Flow From Financing Activity 94-7143072140-14235
Net Proceeds from Shares 0000000300052
Net Proceeds from Borrowing 510-117-900-1362113
Interest Paid -2-2-3-3-4-5-5-5-2-6
Dividend Paid 00000000-11-11
Others 5-3-2017677-18-387
Net Cash Flow 002-203-2821-1
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)31.9959.8336.0737.9435.4529.0639.7221.115.096.94
ROCE (%)25.0342.7335.837.7635.0226.6833.0523.8820.6710.22
Asset Turnover Ratio2.32.051.61.421.281.091.070.980.870.75
PAT to CFO Conversion(x)-10.772.420.560.8810.5-0.140.672.3
Working Capital Days
Receivable Days6272838495959298116118
Inventory Days41404546516960616872
Payable Days9497128139142170138136142122

AMI Organics Ltd Stock News

AMI Organics Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of AMI Organics on 31-Oct-2024 16:01 is ₹1,976.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Oct-2024 16:01 the market cap of AMI Organics stood at ₹8,092.1.
The latest P/E ratio of AMI Organics as of 31-Oct-2024 16:01 is 81.59.
The latest P/B ratio of AMI Organics as of 31-Oct-2024 16:01 is 6.72.
The 52-week high of AMI Organics is ₹1,987.4 and the 52-week low is ₹1,005.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of AMI Organics is ₹796.4 ( Cr.) .

About AMI Organics Ltd

Ami Organics is a research and development (R&D) driven manufacturer of specialty chemicals with varied end usage, focused towards the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates) for regulated and generic active pharmaceutical ingredients (APIs) and New Chemical Entities (NCE) and key starting material for agrochemical and fine chemicals, especially from its recent acquisition of the business of Gujarat Organics (GOL) (Acquisition). The company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Pharma Intermediates which it manufacture, find application in certain high-growth therapeutic areas including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant, commanding significant market share both in India and globally.

The company has developed and commercialized over 450 Pharma Intermediates for APIs across 17 key therapeutic areas since inception and NCE, with a strong focus on R&D across select high-growth high margin therapeutic areas such as anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant, for use across the global pharmaceutical market. In addition, the company recently completed the acquisition of two additional manufacturing facilities operated by GOL which has added preservatives (parabens and parabens formulations which have end usage in cosmetics, animal food and personal care industries) and other specialty chemicals (with end usage in inter alia the cosmetics, dyes polymers and agrochemicals industries) in its existing product portfolio, which command significant market share globally in the supply of certain paraben derivatives. The acquisition is in line with company’s inorganic growth strategy of foraying further into the specialty chemicals sector and it will enable it to significantly diversify its existing product portfolio, with an objective of attaining inorganic expansion of its business.

Business area of the company

The company is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.

Awards, accreditations or recognitions

  • 2005: Gujarat Gas Safety Award for developing and implementing effective HSE Management System by Gujarat Gas Company Limited.
  • 2016: Obtained certifications for ISO 9001:2015 and ISO 14001:2015.
  • 2017: Outstanding export performance “Second Award” under the category of Panel - II: Inorganic, Organic and Agro Chemicals - (SSM) for the year 2016-17.
  • 2018: Conferred the title of the “Best Recuiter” by Uka Tarsadia University, Bardoli.
  • 2018: Recognition by the Directorate General of Foreign Trade with status of ‘Two Star Export House’.
  • 2018: Certified by the Central Board of Indirect Taxes and Customs as ‘Authorised Economic Operator’ in recognition and appreciation of Company’s commitment to secure international supply chain and compliance with ‘WCO’s SAFE Framework of Standards’.
  • 2018: Obtained certification for SA 8000:2014.
  • 2018: “Business Innovation Award” under Dare to Dream awards by SAP.
  • 2019: Obtained certification for ISO 45001:2018.
  • 2021: Award for Excellence in the ‘Research in Science & Technology’ category by the Federation of Gujarat Industries.
  • 2021: Fairdeal Filaments Awards for Outstanding Entrepreneur in MSME Segment by the Southern Gujarat Chamber of Commerce & Industry.

Major events and milestones

  • 2004: Formation of partnership firm in the name of “Ami Organics”.
  • 2007: Ami Organics changed its constitution into Ami Organics Private Limited.
  • 2011: Implemented the Integrated Management System (IMS).
  • 2015: Achieved turnover of Rs 1,000 million.
  • 2015: Incorporated Ami Onco-Theranostics, LLC in USA along with Photolitec LLC.
  • 2016: Established a tertiary effluent treatment plant to become zero liquid discharge plant.
  • 2016: Received recognition from the Department of Scientific and Industrial Research for company's in-house research and development (R&D) unit.
  • 2017: Increased warehouse capacity by establishing a warehouse equipped with modern infrastructure including fire and safety and having a storage capacity of 1050 metric ton (MT) of raw material.
  • 2017: Achieved turnover of Rs 1,500 million.
  • 2017: Applied for process patents for five products in India.
  • 2018: Completed assessment of and established a good manufacturing practice (GMP) compliant facility at company’s production site and warehouse in Surat, Gujarat.
  • 2018: Applied for process patents for three additional products in India.
  • 2018: Converted Ami Organics Private Limited into a public limited company, Ami Organics Limited.
  • 2018: Received first establishment inspection report (“EIR”) from the United States Food and Drug Administration (“USFDA”).
  • 2020: Received second EIR from USFDA for the manufacturing facility at Surat, Gujarat.
  • 2020: Commencement of a new research and development laboratory at Sachin, Surat, Gujarat.
  • 2020: Commencement of the new solvent recovery plant at Sachin, Surat, Gujarat.
  • 2021: Acquisition of the Ankleshwar and Jhagadia units from Gujarat Organics Limited.
  • 2021: Applied for process patents for three additional products in India.


Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.